mRNA expression
Gene:
MAGEA10 (official gene symbol)Other symbol:
MAGEA10CT family:
CT1CT identifier:
CT1.10Aliases from NCBI:
MAGE10 , MGC10599Gene expression pattern ? : Testis-selective
High-throughput data (expression in cancer samples)
SAGE(short, 10 nt tags) Show
SAGE(long, 17 nt tags) Show
MPSS (short, 13 nt tags) Show
EST Show
Validation by Ludwig Institute of Cancer Research of mRNA expression in normal tissues and cell lines (RT-PCR)
Show![]() | ||
![]() | ||
The figures shown in this section represent a standardized analysis of all reported CT-antigens in the same set of mRNA preparations from
normal human tissues and a selection of human cancer cell lines. The analysis was done by RT-PCR using the primer pairs indicated for each gene.
A total of 1.0 �g of RNA was reverse-transcribed into cDNA using the Omniscript RT kit (Qiagen, Valencia, CA) using oligo (dT)18 primers
(Invitrogen, Carlsbad, CA). JumpStart REDTaq� ReadyMix-(Sigma Aldrich, St. Louis,MO) was used for amplification according to the manufacturer's
instructions. Samples were amplified with a precycling hold at 95oC for 3 min, followed by 35 specific cycles of denaturation at 95oC
for 15 seconds,annealing for 30 seconds (10 cycles at 60oC, 10 cycles at 58oC and 15 cycles at 56oC) and extension at 72oC for 30 seconds followed by a final
extension step at 72oC for 7 minutes. The RT-PCR products were run on 1.5% agarose gels and stained by ethidium bromide. |
Published data of mRNA expression in normal tissues
ShowTissue | Methodology | PMID |
---|---|---|
Testis | Oligonucleotide microarray | 11751535 |
Fetal keratinocytes | qRT-PCR | 17993289 |
Keratinocytes | qRT-PCR | 17993289 |
Published data of mRNA expression in neoplasias
Hematologic malignacies Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Monoclonal gammopathy of undetermined significance (MGUS) |
0/6 (0%) | RT-PCR | 10438702 | |
Myeloma |
0/2 (0%)(stage II) | RT-PCR | ||
Myeloma |
0/9 (0%)(stage I) | RT-PCR | ||
Myeloma |
2/26 (7.7%)(stage III) | RT-PCR | ||
Monoclonal gammopathy of undetermined significance (MGUS) |
1/6 (17%) | RT-PCR | 15761016 | |
Myeloma |
2/10 (20%) | RT-PCR | ||
Adult T-cell leukemia/lymphoma (ATLL) |
0/33 (0%) | RT-PCR | 22323448 |
Bladder cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Non-muscle-invasie bladder carcinoma |
24/74 (32%) | qRT-PCR | 23125074 |
Brain cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Medulloblastoma (Pediatric) |
1/11 (9%) | qRT-PCR | 18398575 | |
Glioma |
1/30 (3%) | RT-PCR | 18240144 |
Gastric cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Gastrict carcinoma |
Primary tumor | 0/15 (0%)(stage I) | in situ hybridization | 18594524 |
Gastrict carcinoma |
Metastatic tumor | 32/41 (80%) | in situ hybridization | |
Gastrict carcinoma |
Primary tumor | 4/15 (27%)(stage II-IV) | in situ hybridization |
Head & Neck cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Squamous cell carcinoma |
Primary tumor | 12/57 (22%) | RT-PCR | 20715104 |
Hepatobiliary cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Hepatocellular carcinoma |
11/30 (36.7%) | RT-PCR | 15723723 | |
Hepatocellular carcinoma |
3/6 (50%) | RT-PCR | 15661935 | |
Hepatocellular carcinoma |
8/22 (36%) | RT-PCR | 10189127 |
Lung cancer Show
Tumor Subtype | Sample type | Frequency | Methodology | PMID |
---|---|---|---|---|
Adenocarcinoma |
1/22 (4.5%) | RT-PCR | 14512184 | |
Adenosquamous carcinoma |
0/1 (0%) | RT-PCR | ||
Large cell carcinoma |
1/6 (6.2%) | RT-PCR | ||
Squamous cell carcinoma |
5/13 (38%) | RT-PCR | ||
Adenocarcinoma |
21/84 (25%) | RT-PCR | 16299236 | |
Squamous cell carcinoma |
21/42 (50%) | RT-PCR |
Published data of mRNA expression in Cell Lines
ShowOrigin tissue | Cell Line ID | Frequency | Methodology | PMID |
---|---|---|---|---|
Adult keratinocyte cell line | NHEK | RT-PCR | 19358718 | |
Melanoma | WM1976-A WM3130-A |
2/4 (50%) | RT-PCR | 18205182 |
Melanoma | Sk-Mel-37 Sk-Mel-28 Malme-3M |
3/5 (60%) | RT-PCR | 18395366 |
Melanoma | LB1751-MEL LB373-MEL AVL3-MEL LB1448-MEL2 LB583-MEL6 LB1781-MEL MZ2-MEL.3.0 |
7/9 (78%) | Oligonucleotide microarray | 11751535 |
Melanoma stem cells (MSC) | WM1972-NA WM1976-NA WM3130-NA |
3/4 (75%) | RT-PCR | 18205182 |
Oral squamous cell carcinoma | PCI13-11 PCI1-1 PCI52 PCI68-1 |
4/4 (100%) | RT-PCR | 19358718 |
Sarcoma | SW872 | 1/7 (14%) | RT-PCR | 15298487 |
2005-2009© CT Antigens Database